Table 7. Major adverse cardiovascular events of the patients with CAD followed-up.

MACE	Male (n = 249)			Female(n = 159)
	CT group(n = 63)	NCT group(n = 186)	p value	CT group(n = 74)	NCT group(n = 85)	p value
the primary end point
cardiac death	0(0)	3(1.6)	0.311	2(2.7 )	3(3.5 )	0.766
cardiac death due to CAD	0(0)	3(1.6)	0.311	1(1.4)	3(3.5)	0.382
acute myocardial infarction	2(3.2)	11(5.9)	0.398	3(4.1 )	2(2.4)	0.540
the secondary end point
all cause mortality	1(1.6)	6(3.2)	0.496	3(4.1)	4(4.7)	0.842
coronary revascularization	6(9.5)	24(12.9)	0.476	7(9.5 )	15(17.6)	0.136
non-fatal angina needing hospital admission	23(36.5)	74(39.8)	0.645	27(36.5 )	29(34.1)	0.755
stroke	6(9.5)	23(12.4)	0.543	6(8.1)	10(11. 8)	0.445
composite end point	26(41.3)	89(47.8)	0.365	31( 41.9)	36(42.4)	0.953